Basic Information
Foclivia
Regulatory Information
EMEA/H/C/001208
October 18, 2009
July 23, 2009
13
October 3, 2023
Company Information
Italy
Via del Pozzo 3/A S. Martino 53035 Monteriggioni (SI)
SEQIRUS SRL
Drug Classification
Active Substances Detail
influenza virus surface antigens, inactivated: A/Viet Nam/1194/2004 (H5N1)
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance.
Overview Summary
Foclivia is a vaccine used in adults to protect against flu when a ‘pandemic’ has been officially declared by the World Health Organization (WHO) or the European Union (EU). A flu pandemic occurs when a new type (strain) of flu virus can spread easily from person to person because people have no immunity (protection) against it. A pandemic can affect most countries and regions around the world. Foclivia would be given according to official recommendations. Foclivia contains some parts of inactivated (killed) influenza (flu) virus. It contains a flu strain called A/Vietnam/1194/2004 (H5N1).